RAFAEL HOLDINGS, INC. Increase (Decrease) in Other Receivables
RAFAEL HOLDINGS, INC. (RFL) reported Increase (Decrease) in Other Receivables of -$1.21 million for the 9-month period ending 2026-04-30, per its 10-Q filed 2026-06-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherReceivables · last filed 2026-06-11
- RAFAEL HOLDINGS, INC. increase (decrease) in other receivables for the quarter ending 2026-04-30 was $0.00.
- RAFAEL HOLDINGS, INC. increase (decrease) in other receivables for the quarter ending 2026-01-31 was $0.00.
- RAFAEL HOLDINGS, INC. increase (decrease) in other receivables for the quarter ending 2025-10-31 was -$1.21M.
- RAFAEL HOLDINGS, INC. increase (decrease) in other receivables for the quarter ending 2025-07-31 was $788.00K.
- RAFAEL HOLDINGS, INC. increase (decrease) in other receivables for fiscal 2025 was $273.00K, a 96.40% increase from fiscal 2024.
- RAFAEL HOLDINGS, INC. increase (decrease) in other receivables for fiscal 2024 was $139.00K, a 43.72% decline from fiscal 2023.
- RAFAEL HOLDINGS, INC. increase (decrease) in other receivables for fiscal 2023 was $247.00K, a 76.43% increase from fiscal 2022.
- RAFAEL HOLDINGS, INC. increase (decrease) in other receivables for fiscal 2022 was $140.00K.
| Period end | Increase (Decrease) in Other Receivables 3 month | Increase (Decrease) in Other Receivables 6 month | Increase (Decrease) in Other Receivables 9 month | Increase (Decrease) in Other Receivables 12 month |
|---|---|---|---|---|
| 2026-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-06-11 | $0.00 derived: sum of 2 quarters · filed 2026-06-11 | -$1.21M 10-Q · filed 2026-06-11 | -$418.00K derived: sum of 4 quarters · filed 2026-06-11 |
| 2026-01-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-03-16 | -$1.21M 10-Q · filed 2026-03-16 | -$418.00K derived: sum of 3 quarters · filed 2026-03-16 | -$418.00K derived: sum of 4 quarters · filed 2026-03-16 |
| 2025-10-31 | -$1.21M 10-Q · filed 2025-12-12 | -$418.00K derived: sum of 2 quarters · filed 2025-12-12 | -$418.00K derived: sum of 3 quarters · filed 2025-12-12 | -$856.00K derived: sum of 4 quarters · filed 2025-12-12 |
| 2025-07-31 | $788.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | $788.00K derived: sum of 2 quarters · filed 2025-10-29 | $350.00K derived: sum of 3 quarters · filed 2025-10-29 | $273.00K 10-K · filed 2025-10-29 |
| 2025-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-06-11 | -$438.00K derived: sum of 2 quarters · filed 2025-06-11 | -$515.00K 10-Q · filed 2025-06-11 | -$541.00K derived: sum of 4 quarters · filed 2025-06-11 |
| 2025-01-31 | -$438.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-03-14 | -$515.00K 10-Q · filed 2025-03-14 | -$541.00K derived: sum of 3 quarters · filed 2025-03-14 | -$560.00K derived: sum of 4 quarters · filed 2025-06-11 |
| 2024-10-31 | -$77.00K 10-Q · filed 2024-12-11 | -$103.00K derived: sum of 2 quarters · filed 2024-12-20 | -$122.00K derived: sum of 3 quarters · filed 2025-06-11 | $29.00K derived: sum of 4 quarters · filed 2025-06-11 |
| 2024-07-31 | -$26.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-20 | -$45.00K derived: sum of 2 quarters · filed 2025-06-11 | $106.00K derived: sum of 3 quarters · filed 2025-06-11 | $139.00K 10-K/A · filed 2024-12-20 |
| 2024-04-30 | -$19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-06-11 | $132.00K derived: sum of 2 quarters · filed 2025-06-11 | $165.00K 10-Q · filed 2025-06-11 | $200.00K derived: sum of 4 quarters · filed 2025-06-11 |
| 2024-01-31 | $151.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-03-14 | $184.00K 10-Q · filed 2025-03-14 | $219.00K derived: sum of 3 quarters · filed 2025-03-14 | $257.00K derived: sum of 4 quarters · filed 2025-03-14 |
| 2023-10-31 | $33.00K 10-Q · filed 2024-12-11 | $68.00K derived: sum of 2 quarters · filed 2024-12-20 | $106.00K derived: sum of 3 quarters · filed 2024-12-20 | $249.00K derived: sum of 4 quarters · filed 2024-12-20 |
| 2023-07-31 | $35.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-20 | $73.00K derived: sum of 2 quarters · filed 2024-12-20 | $216.00K derived: sum of 3 quarters · filed 2024-12-20 | $247.00K 10-K/A · filed 2024-12-20 |
| 2023-04-30 | $38.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-06-14 | $181.00K derived: sum of 2 quarters · filed 2024-06-14 | $212.00K 10-Q · filed 2024-06-14 | $94.00K derived: sum of 4 quarters · filed 2024-06-14 |
| 2023-01-31 | $143.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-03-14 | $174.00K 10-Q · filed 2024-03-14 | $56.00K derived: sum of 3 quarters · filed 2024-03-14 | |
| 2022-10-31 | $31.00K 10-Q · filed 2023-12-14 | -$87.00K derived: sum of 2 quarters · filed 2023-12-14 | ||
| 2022-07-31 | -$118.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-30 | $140.00K 10-K · filed 2023-10-30 | ||
| 2022-04-30 | $258.00K 10-Q · filed 2022-06-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |